# Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer

> **NCT00016146** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 34 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** GPI-0100
- **BIOLOGICAL:** MUC-2-Globo H-KLH conjugate vaccine

## Key facts

- **NCT ID:** NCT00016146
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016146, "Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00016146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*